# Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

> **NCT00257530** · PHASE3 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 80 (—)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT00257530
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 80 (—)
- **Last updated:** 2008-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257530, "Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00257530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*